Comparison of Bivalirudin Versus Heparin(s) During Percutaneous Coronary Interventions in Patients Receiving Prasugrel: A Propensity‐Matched Study

ConclusionsIn patients undergoing PCI and treated with prasugrel, the use of BIV rather than HEP ± GPI is associated with significantly lower transfusion rate and LOS. These results suggest that the previously documented safety and cost‐effectiveness benefits of BIV remain applicable when prasugrel is used.

Source: Clinical Cardiology - October 1, 2013 Category: Cardiology Authors: Martial Hamon, Laurent Bonello, Steven Marso, Sunil V. Rao, Marco Valgimigli, Freek Verheugt, Anthony Gershlick, Yamei Wang, Jayne Prats, Gabriel P. Steg, Efthymios Deliargyris Tags: Clinical Investigation Source Type: research